课题基金 / 基金详情

Identifying Regulators of Degeneration due to Defective Mitochondrial DNA

Identifying Regulators of Degeneration due to Defective Mitochondrial DNA
识别由于线粒体 DNA 缺陷引起的退化调节因子
批准号:
10205959
负责人:
MING GUO
金额:
$76.46万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-30 至 2023-05-31
关键词:
AdultAffectAgeAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAmyloid beta-ProteinAutophagocytosisBiologicalBiological AssayBrainCellsCessation of lifeDNA DamageDeletion MutationDiseaseDisease modelDrosophila genusDrosophila melanogasterDrug ScreeningDrug TargetingEngineeringExcisionEyeFDA approvedFinancial compensationFree RadicalsFunctional disorderGene ExpressionGene Expression ProfileGene Expression ProfilingGenesGenetic TranscriptionGenomeGoalsHumanInterventionKnowledgeLeadMitochondriaMitochondrial DNAMitoticModelingMolecularMuscleMutateMutationNerve DegenerationNervous system structureNeurodegenerative DisordersNeuronal DysfunctionNeuronsOrganellesOxidative PhosphorylationPINK1 geneParkinson DiseasePathogenesisPathologyPathway AnalysisPathway interactionsPharmaceutical PreparationsPlayPopulationPrincipal InvestigatorProductionPublic HealthQuality ControlRNA InterferenceReporterResourcesRisk FactorsRoleScreening ResultSourceSystemSystems BiologyTauopathiesTestingTissuesTransgenic ModelTransgenic Organismsage relatedage related neurodegenerationage-related muscle lossbasecell typeexperimental studyfeedingfrailtygain of functiongenome wide screengenome-wideheteroplasmyimprovedin vivoinsightloss of functionmitochondrial DNA mutationmitochondrial dysfunctionmitochondrial genomemuscle degenerationmutantoverexpressionparkin gene/proteinprogramspublic health relevanceresponsesarcopeniatau Proteinstau expressiontool

项目摘要

项目成果

MING GUO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Program Director/Principal Investigator (Last, First, Middle): Guo, Ming Project Summary/Abstract Neurodegenerative disorders affect 50% of the population over the age of 85. The strongest risk factor for most neurodegenerative disorders including Alzheimer’s disease is aging. Accumulation of mitochondrial DNA (mtDNA) mutations leads to cellular dysfunction, contributes to human aging and can be observed in age-related diseases such as Alzheimer’s disease, Parkinson’s disease and sarcopenia. Strategies that reduce the mtDNA deleterious mutation load and improve mtDNA quality control are likely to reduce the age-related pathologies of neurodegenerative diseases. We have generated unique transgenic tools in living Drosophila melanogaster post-mitotic tissues that contain engineered mixed mtDNA deletion mutations (deleterious heteroplasmy models). We aim to use these systems and system biology approaches to identify genes and compounds that lead to suppression or enhancement of the mitochondrial DNA quality control. OMB No. 0925-0001/0002 (Rev. 03/16 Approved Through 10/31/2018) Page Continuation Format Page
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Academic Career Leadership Award in Aging
Academic Career Leadership Award in Aging
Academic Career Leadership Award in Aging
Identifying Regulators of Degeneration due to Defective Mitochondrial DNA
海外基金